| Cat. No. | Species | Product Description | Structure | Purity | Feature |
|---|---|---|---|---|---|
| LIT-H5269 | Human | Human LIGHT / TNFSF14 Protein, Fc Tag (active trimer) (MALS verified) |
|
|
|
| LIT-H5242 | Human | Human LIGHT / TNFSF14 Protein, His Tag (active trimer) (MALS verified) |
|
|
|
| LIT-H5256 | Human | Human LIGHT / TNFSF14 Protein, Mouse IgG2a Fc Tag, low endotoxin |  |
|
|
Human LIGHT, Fc Tag (active trimer) (MALS verified) (Cat. No. LIT-H5269) induced cytotoxicity in HT-29 cells. The ED50 for this effect is 1.29-2.38 ng/mL (Routinely tested).
Loaded Human DcR3, Fc Tag (Cat. No. TNB-H5255) on AHC Biosensor, can bind Human LIGHT, Mouse IgG2a Fc Tag, low endotoxin (Cat. No. LIT-H5256) with an affinity constant of 1.64 nM as determined in BLI assay (ForteBio Octet Red96e) (Routinely tested).
| Name | Research Code | Research Phase | Company | Indications | Clinical Trials |
|---|---|---|---|---|---|
| Quisovalimab | MDGN-002; SAR-252067; AVTX-002; AEVI-002; CERC-002 | Phase 2 Clinical | La Jolla Pharmaceutical Company, Kyowa Hakko Kirin | Coronavirus Disease 2019 (COVID-19); Respiratory Distress Syndrome, Adult; Colitis, Ulcerative; Crohn Disease; Acute Lung Injury | Details |
This web search service is supported by Google Inc.
A-Z
